Infertility

5 trials MedDRA PT
5 Registered trials
0 Recruiting
5 Unique sponsors
7 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 3
G Urology/Gynaecology (ATC G) 2
H Endocrinology (ATC H) 1
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 5 substances
Gonadotropin / pituitary hormone 2 substances
Phase III: 1 Phase IV: 2 Phase I: 1 Other: 1

Filter these 5 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 5 trials

Phase III

1 trial
  • Assistance Publique Hopitaux De Paris Academic
    CPFT TRIFLUOROACETATE
    2024-514350-78-00 1 country 2021 n=366
    Ended

Phase IV

2 trials
  • Santiago Dexeus Font Fundacio Privada Academic
    CHORIOGONADOTROPIN ALFA; CLOMIFENE CITRATE; FOLLITROPIN ALFA (GENETICAL RECOMBINATION); GANIRELIX; PROGESTERONE, MICRONISED; TRIPTORELIN
    2024-514322-23-00 1 country 2024 n=110
    Ended
  • University Medical Center Utrecht Academic
    PROGESTERONE, MICRONISED
    2022-501534-33-00 1 country 2023 n=1,008
    Ended

Phase I

1 trial
  • Freya Biosciences ApS Commercial
    IMP not specified
    2024-517539-38-00 1 country 2025 n=89
    Ended

Other

1 trial
  • Xentria Inc. Commercial
    IMP not specified
    2025-523368-19-00 1 country n=48
    Not authorised
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Freya Biosciences ApS Commercial 1 Phase I 0
Xentria Inc. Commercial 1 Other 0
Assistance Publique Hopitaux De Paris Academic 1 Phase III 0
Santiago Dexeus Font Fundacio Privada Academic 1 Phase IV 0
University Medical Center Utrecht Academic 1 Phase IV 0
New trials by year
2021
1
2023
1
2024
1
2025
1
← All indication landscapes